Tommola P, Pekonen F, Rutanen E M
Minerva Institute for Medical Research, Kauniainen, Finland.
Obstet Gynecol. 1989 Oct;74(4):658-62.
Samples of uterine myometrium and leiomyoma from 11 women were analyzed for the presence of epidermal growth factor receptors and insulin-like growth factor I receptors. In addition, the content of soluble insulin-like growth factor binding protein (IGF-BP/PP12) was measured in the tissue cytosols. Cell membrane preparations of myoma tissue bound significantly more insulin-like growth factor I than did those of adjacent normal myometrium, whereas myoma tissue bound less epidermal growth factor than did the normal myometrium. The differences in both insulin-like growth factor I and epidermal growth factor binding were due to changes in receptor concentration rather than to alterations in receptor affinity. Neither myoma nor myometrial tissue contained detectable levels of insulin-like growth factor binding protein. The changes in epidermal growth factor and insulin-like growth factor I binding to the myometrium may play a role in the pathogenesis of uterine leiomyomata.
对11名女性的子宫肌层和子宫肌瘤样本进行分析,以检测表皮生长因子受体和胰岛素样生长因子I受体的存在情况。此外,还测定了组织胞质溶胶中可溶性胰岛素样生长因子结合蛋白(IGF-BP/PP12)的含量。肌瘤组织的细胞膜制剂比相邻正常子宫肌层的制剂结合的胰岛素样生长因子I显著更多,而肌瘤组织结合的表皮生长因子比正常子宫肌层更少。胰岛素样生长因子I和表皮生长因子结合的差异是由于受体浓度的变化,而非受体亲和力的改变。肌瘤组织和子宫肌层组织均未检测到可检测水平的胰岛素样生长因子结合蛋白。表皮生长因子和胰岛素样生长因子I与子宫肌层结合的变化可能在子宫平滑肌瘤的发病机制中起作用。